Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term uterine cervix. Found 22 abstracts

no pagination
Alberts DS, Blessing JA, Landrum LM, Warshal DP, Martin LP, Rose SL, Bonebrake AJ, Ramondetta LM. Phase II trial of nab-paclitaxel in the treatment of recurrent or persistent advanced cervix cancer: A gynecologic oncology group study. Gynecologic Oncology. 2012 Dec;127(3):451-5.   PMCID: NIHMS342821
Cantor SB, Yamal JM, Guillaud M, Cox DD, Atkinson EN, Benedet JL, Miller D, Ehlen T, Matisic J, van Niekerk D, Bertrand M, Milbourne A, Rhodes H, Malpica A, Staerkel G, Nader-Eftekhari S, Adler-Storthz K, Scheurer ME, Basen-Engquist K, Shinn E, West LA, Vlastos AT, Tao X, Beck JR, MacAulay C, Follen M. Accuracy of optical spectroscopy for the detection of cervical intraepithelial neoplasia: testing a device as an adjunct to colposcopy. International journal of cancer. 2011 Mar;128(5):1151-68.   PMCID: PMC3015005
Farley J, Sill MW, Birrer M, Walker J, Schilder RJ, Thigpen JT, Coleman RL, Miller BE, Rose PG, Lankes HA. Phase II study of cisplatin plus cetuximab in advanced, recurrent, and previously treated cancers of the cervix and evaluation of epidermal growth factor receptor immunohistochemical expression: A Gynecologic Oncology Group study. Gynecologic Oncology. 2011 May;121(2):303-8.   PMCID: PMC3081894
Greer BE, Koh WJ, Abu-Rustum NR, Apte SM, Campos SM, Chan J, Cho KR, Copeland L, Crispens MA, DuPont N, Eifel PJ, Gaffney DK, Huh WK, Kapp DS, Lurain JR, Martin L, Morgan MA, Morgan RJ, Mutch D, Remmenga SW, Reynolds RK, Small W, Teng N, Valea FA. Cervical Cancer. Journal of the National Comprehensive Cancer Network. 2010 Dec;8(12):1388-416.   PMCID: not NIH funded
Schilder RJ, Blessing J, Cohn DE. Evaluation of gemcitabine in previously treated patients with non-squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group. Gynecologic Oncology. 2005 Jan;96(1):103-7.
Al Moustafa AE, Foulkes WD, Wong A, Jallal H, Batist G, Yu QY, Herlyn M, Sicinski P, Alaoui-Jamali MA. Cyclin D1 is essential for neoplastic transformation induced by both E6/E7 and E6/E7/ErbB-2 cooperation in normal cells. Oncogene. 2004 Jul;23(30):5252-6.
Bruening W, Prowse AH, Schultz DC, Holgado-Madruga M, Wong A, Godwin AK. Expression of OVCA1, a candidate tumor suppressor, is reduced in tumors and inhibits growth of ovarian cancer cells. Cancer Research. 1999 Oct;59(19):4973-83.
Movsas B, Chapman JD, Horwitz EM, Pinover WH, Greenberg RE, Hanlon AL, Iyer R, Hanks GE. Hypoxic regions exist in human prostate carcinoma. Urology. 1999 Jan;53(1):11-8.
Chapman JD, Engelhardt EL, Stobbe CC, Schneider RF, Gerald GE. Measuring hypoxia and predicting tumor radioresistance with nuclear medicine assays. Radiotherapy and Oncology. 1998 Mar;46(3):229-37.
Iyer RV, Engelhardt EL, Stobbe CC, Schneider RF, Chapman JD. Preclinical assessment of hypoxic marker specificity and sensitivity. International Journal of Radiation Oncology Biology Physics. 1998 Nov;42(4):741-5.
Corn BW, Lanciano RM, Dagostino R, Kiggundu E, Dunton CJ, Purser P, Greven KM. The relationship of local and distant failure from endometrial cancer: Defining a clinical paradigm. Gynecologic Oncology. 1997 Sep;66(3):411-6.
Corn BW, Shaktman BD, Lanciano RM, Hogan WM, Cater JR, Anderson L, Heller P, Hernandez E. Intra- and perioperative complications associated with tandem and colpostat application for cervix cancer. Gynecologic Oncology. 1997 Feb;64(2):224-9.
Bonin SR, Lanciano RM, Corn BW, Hogan WM, Hartz WH, Hanks GE. Bony landmarks are not an adequate substitute for lymphangiography in defining pelvic lymph node location for the treatment of cervical cancer with radiotherapy. International Journal of Radiation Oncology Biology Physics. 1996 Jan;34(1):167-72.
Lattanzi J, Erickson B. Patterns of recurrence following hysterectomy and radiation for cervical carcinoma: Relationship to residual disease and brachytherapy techniques. International Journal of Gynecological Cancer. 1996 Sep;6(5):396-404.
Lesack D, Wahab I, Gilks CB. Radiation-induced atypia of endocervical epithelium: A histological, immunohistochemical and cytometric study. International Journal of Gynecological Pathology. 1996 Jul;15(3):242-7.
Ling CC, Smith AR, Hanlon AL, Owen JB, Brickner TJ, Hanks GE. Treatment planning for carcinoma of the cervix: A patterns of care study report. International Journal of Radiation Oncology Biology Physics. 1996 Jan;34(1):13-9.
Fein DA, Lee WR, Hanlon AL, Ridge JA, Langer CJ, Curran WJ, Coia LR. Pretreatment Hemoglobin Level Influences Local-Control and Survival of T1-T2 Squamous-Cell Carcinomas of the Glottic Larynx. Journal of Clinical Oncology. 1995 Aug;13(8):2077-83.
Yeh KA, Biade S, Lanciano RM, Brown DQ, Fenning MC, Babb JS, Hanks GE, Chapman JD. Polarographic Needle Electrode Measurements of Oxygen in Rat Prostate Carcinomas - Accuracy and Reproducibility. International Journal of Radiation Oncology Biology Physics. 1995 Aug 30;33(1):111-8.
Bruner DW, Lanciano R, Keegan M, Corn B, Martin E, Hanks GE. Vaginal Stenosis and Sexual Function Following Intracavitary Radiation for the Treatment of Cervical and Endometrial Carcinoma. International Journal of Radiation Oncology Biology Physics. 1993 Nov 15;27(4):825-30.
Lanciano RM, Pajak TF, Martz K, Hanks GE. The Influence of Treatment Time on Outcome for Squamous-Cell Cancer of the Uterine Cervix Treated with Radiation - a Patterns-of-Care Study. International Journal of Radiation Oncology Biology Physics. 1993 Feb 15;25(3):391-7.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term uterine cervix

uterine cervix carcinoma squamous-cell carcinoma cancer tumor hypoxia advanced cancer radiation-therapy breast-cancer misonidazole binding irradiation photodynamic therapy therapy paclitaxel neck postoperative irradiation morbidity cervical cancer external hysterectomy head trial prognostic factors survival hypoxia radiotherapy plus cisplatin cowden-disease chromosome radical endocervix gemcitabine in-vivo detection antitumor-activity f-18 complications gynecologic positron emission tomography perineal applicator mupit treatment time 13 european countries multivariate-analysis ultrasound squamous cell cancer nonsquamous carcinomas hypoxic marker cervical carcinoma prostate carcinoma bioreducible markers erythropoietin intracavitary radiation of-the-literature formulation oncology cervical-cancer k-ras activation colorectal-cancer dose distribution multispectral digital colposcopy iodoazomycin arabinoside solid tumors ultrasonography lung-cancer oxygen distribution NCCN Guidelines anemia adenocarcinoma primary radiotherapy platinum primitive neuroectodermal tumors cells-invitro gene amplification PET oxygenation predicts radiation therapy NCCN Clinical Practice Guidelines excitation wavelengths cancer-patients sexual function Cisplatin tissue fluorescence-spectra radical hysterectomy treatment standards genetic alterations prostate-cancer human-papillomavirus infection positron-emission-tomography monoclonal-antibody c225 phase-ii trial metastatic dissemination imaging national practice tumor oxygenation ploidy squamous-cell-carcinoma gynecologic malignancies light-scattering radiation treatment growth-factor tissue chemotherapy diagnosis sensitivity and specificity-early detection of cancer-uterine cervical neoplasms-cervical intraepithelial neoplasia split-course adenocarcinoma insitu pelvic 17p133 surgical staging system p0(2) histograph 2-stage designs larynx p53 vocal cord carcinoma lymphangiogram allelic loss lymphadenectomy Cervical cancer tumors oxygen electrode dose-fractionation pelvic radiation-therapy menstrual-cycle mouse-tumors DNA content stage iib human papillomavirus reflectance spectroscopy brachytherapy technetium chelate gynecologic brachytherapy expression murine tumors gynecologic-oncology-group stage-ib time perforation diagnostic settings long-term albumin-bound vaginal stenosis radiation atypia situ iliac lymph nodes ib azomycin nucleoside non-squamous cell cervical cancer oxygenation Cetuximab tumor bladder fluoromisonidazole metastasis
Last updated on Wednesday, July 08, 2020